News
Insights from Ron
These posts reflect my experience as a research scientist and the founder of numerous biotechnology companies. They include insights into pressing scientific problems, such as combating SARS-Cov-2. I write here about the significant after-effects of COVID-19 on clinical research participation and a rise of pulmonary fibrosis. A year-end roundup of the year’s most exciting research is a popular feature – the 2020 roundup will appear in January. This year, I also offer a challenge, comparing our current moment to the Sputnik Moment in 1957, with its major shifts in science, education, and social change.
Be sure to visit our other Media topics, such as the Biotechnology Entrepreneurship, Leadership Series, Features, and Ron in the News.
Tvardi Therapeutics: Fiercely Focused on STAT3 Inhibitors
According to life sciences publisher Fierce Biotech, what sets Tvardi Therapeutics apart from other early-stage biotech startups is that “it …
Cancer Research and Investment Opportunities
Cancer exacts a steep social and economic toll, especially as an aging world population creates increased cancer rates. The investment …
$74 million Series B Funding for Tvardi Therapeutics
As a Co-Founder and former Chairman of the Board I’m excited to announce that we’ve closed a $74 million Series …
Watch On-Demand Sessions: 2021 Fifth International Vatican Council
You can now view all of the speaker sessions from the May 6-8 Fifth International Vatican Conference on the conference website. …
Eliminate Flavored Tobacco and Reduce Nicotine to Non-addictive Levels
The U.S. Food & Drug Administration’s announcement on April 29th of a timeline leading to a full ban on mentholated …
Cancer Moonshots Stronger than Ever
Since the launch in 2016 of the Cancer Moonshots program under the National Cures Act, the National Cancer Institute (NCI) …
